Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
Journal: Journal of drugs in dermatology : JDD
Published: September 21, 2018
Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 0.05% Versus Its Vehicle in Adult Subjects With Plaque Psoriasis.
Journal: Journal of drugs in dermatology : JDD
Published: March 17, 2017
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.
Journal: Journal of the American Academy of Dermatology
Published: February 23, 2017
Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open-Label, Maximal-Use Systemic Exposure Study.
Journal: Pediatric dermatology
Published: May 20, 2016
Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
Journal: Journal of drugs in dermatology : JDD
Published: February 05, 2013
Showing 1-5 of 5
Last Updated: 09/26/2026